Lakefront Biotherapeutics NV (AMS:LKFT)

AMS:LKFT Revenue

Lakefront Biotherapeutics NV had revenue of 6.48M EUR in the quarter ending March 31, 2026, a decrease of -91.36%. This brings the company's revenue in the last twelve months to 1.04B, up 262.17% year-over-year. In the year 2025, Lakefront Biotherapeutics NV had annual revenue of 1.11B with 303.50% growth.

• Revenue (ttm): 1.04B
• Revenue Growth: +262.17%
• P/S Ratio: 1.51
• Revenue / Employee: 1.48M
• Employees: 558
• Market Cap: 1.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.11B	836.60M	303.50%
Dec 31, 2024	275.65M	35.93M	14.99%
Dec 31, 2023	239.72M	-1.53M	-0.63%
Dec 31, 2022	241.25M	85.33M	54.73%
Dec 31, 2017	155.92M	4.31M	2.84%
Dec 31, 2016	151.61M	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 24, 2026

Data Sources Report a data error